Perfil
David T.
Howard held several positions in various companies throughout his career.
He was the Chairman and Chief Executive Officer of SCOLR Pharma, Inc. from 2000 to 2005, Chairman of Angiotech Pharmaceuticals, Inc. from 2000 to 2011, and Chairman of Luminor Medical Technologies, Inc. from 2011 to 2012.
He also served as a Director in several companies such as VIA Pharmaceuticals, Inc., biOasis Technologies, Inc., and Calyx Ventures, Inc. Additionally, he was the President of Novopharm USA, Inc. and Novopharm International, and Vice President-Pharmaceuticals of Boehringer Mannheim Canada Ltd. Howard received his undergraduate degree from the University of Saskatchewan.
Antiguos cargos conocidos de David T. Howard.
| Empresas | Cargo | Fin |
|---|---|---|
| CALYX VENTURES INC. | Director/Miembro de la Junta | 16/12/2014 |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Presidente | 16/04/2012 |
| BIOASIS TECHNOLOGIES INC. | Director/Miembro de la Junta | 24/06/2011 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Presidente | 12/05/2011 |
| SCOLR PHARMA INC. | Presidente | 01/06/2005 |
Formación de David T. Howard.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 15 |
|---|---|
SCOLR Pharma, Inc.
SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel prescription pharmaceutical, over-the-counter and nutritional products | Health Technology |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
SMC Ventures, Inc.
SMC Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a development stage company | Commercial Services |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
SemBioSys Genetics, Inc.
SemBioSys Genetics, Inc. BiotechnologyHealth Technology Develops protein-based pharmaceuticals and non-pharmaceutical products | Health Technology |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Health Technology |
University of Saskatchewan
University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Richardson International Ltd.
Richardson International Ltd. Agricultural Commodities/MillingProcess Industries Provides agribusiness and food processing services that includes grain merchandising, milling & packaging of canola oil products | Process Industries |
VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
159230 Canada, Inc.
159230 Canada, Inc. Financial ConglomeratesFinance 159230 Canada, Inc. is a company based in Vancouver, Canada. | Finance |
Novopharm USA, Inc. | |
Novopharm International | |
Boehringer Mannheim Canada Ltd. | |
biOasis Technologies, Inc.
biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Calyx Ventures, Inc.
Calyx Ventures, Inc. Information Technology ServicesTechnology Services Develops custom software for enterprises and start-up companies | Technology Services |
- Bolsa de valores
- Insiders
- David T. Howard
















